Norlase ApS

Norlase ApS is a Danish ophthalmic laser manufacturer specializing in portable, battery-powered laser photocoagulation systems for retinal disease treatment. The company designs and sells compact laser devices that integrate directly into existing clinical workflows, eliminating the need for external consoles, fiber tethers, or wall power. Product lines include LEAF (green laser photocoagulator attachable to slit lamps), LION (battery-powered laser indirect ophthalmoscope with wireless controls and voice activation), ECHO (pattern scanning laser photocoagulator with MEMS technology), and LYNX (pattern scanning laser indirect ophthalmoscope). All products deliver green laser therapy for conditions including age-related macular degeneration, glaucoma, and retinal holes. Norlase emphasizes portability, treatment flexibility, and practice efficiency. The company maintains dual operations in Denmark (headquarters in Ballerup) and the United States (Redwood City, California). Recent news indicates strong global growth (40% install base increase in 2025) and secured €20 million in venture debt financing. Products are marketed with operator manuals, clinical resources, and distributor networks. No specific FDA 510(k), CE, or ISO certifications are mentioned on the homepage, though regulatory references suggest market approval in multiple jurisdictions.